Clinical Trials Logo

Clinical Trial Summary

Cystoid macular edema (CME) is one of the common causes of vision loss in patients with UveitiS .Triamcinolone has been effectively used in reducing CME and improving the vision. Also there are some documents which recommend Bevacizumab(avastin) could reduce macular edema. This study compare intravitreous injection of triamcinolone and avastin in patients with resistant uveitic cystoid macular edema.


Clinical Trial Description

This study compare intravitreous injection of triamcinolone and avastin in patients with resistant uveitic cystoid macular edema. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00371111
Study type Interventional
Source hahid Beheshti University of Medical Sciences
Contact
Status Active, not recruiting
Phase Phase 1
Start date August 2006
Completion date September 2008